UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat refractory acute GVHD

Blood, 2007-05, Vol.109 (10), p.4119-4126

Deeg, H. Joachim

2007

Volltextzugriff (PDF)

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

Annals of internal medicine, 2020-02, Vol.172 (4), p.229

2020

Volltextzugriff (PDF)

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1154-1161

2017

Volltextzugriff (PDF)

Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53 -Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes

Journal of clinical oncology, 2022-12, Vol.40 (34), p.3985-3993

2022

Volltextzugriff (PDF)

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Cancer cell, 2015-05, Vol.27 (5), p.617-630

2015

Volltextzugriff (PDF)

Silver Lining: Reduced Relapse with Chronic GVHD after Transplant for MDS

Clinical cancer research, 2020-12, Vol.26 (24), p.6404-6405

2020

Volltextzugriff (PDF)

Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party

Leukemia, 2021-09, Vol.35 (9), p.2445-2459

2021

Volltextzugriff (PDF)

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

Blood, 2019-06, Vol.133 (26), p.2790-2799

2019

Volltextzugriff (PDF)

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

Journal of clinical oncology, 2010-02, Vol.28 (6), p.1011-1016

2010

Volltextzugriff (PDF)

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3249-3256

2014

Volltextzugriff (PDF)

Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1268-1272

2020

Volltextzugriff (PDF)

A disease risk index for patients undergoing allogeneic stem cell transplantation

Blood, 2012-07, Vol.120 (4), p.905-913

2012

Volltextzugriff (PDF)

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

Blood, 2022-03, Vol.139 (11), p.1694-1706

2022

Volltextzugriff (PDF)

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

Blood, 2009-05, Vol.113 (20), p.4992-5001

2009

Volltextzugriff (PDF)

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2662-2670

2013

Volltextzugriff (PDF)

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Blood, 2012-03, Vol.119 (11), p.2657-2664

2012

Volltextzugriff (PDF)

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4246-4254

2007

Volltextzugriff (PDF)

Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML

Leukemia, 2020-06, Vol.34 (6), p.1577-1587

2020

Volltextzugriff (PDF)

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

Blood, 2011-09, Vol.118 (9), p.2618-2621

2011

Volltextzugriff (PDF)

Asymmetric dimethylarginine - a prognostic marker for transplant outcome?

Haematologica (Roma), 2019-04, Vol.104 (4), p.646-647

2019

Volltextzugriff (PDF)

Who is fit for allogeneic transplantation?

Blood, 2010-12, Vol.116 (23), p.4762-4770

2010

Volltextzugriff (PDF)

Elevated TWIST1 expression in myelodysplastic syndromes/acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine

Haematologica (Roma), 2020-01, Vol.105 (10), p.e502

2020

Volltextzugriff (PDF)

Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies

Journal of hematology and oncology, 2016-12, Vol.9 (1), p.137-12, Article 137

2016

Volltextzugriff (PDF)

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia

Haematologica (Roma), 2017-07, Vol.102 (7), p.1291-1298

2017

Volltextzugriff (PDF)

1 – 25 von 608

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(532)
Mit Volltextzugriff
(491)

Publikationsform

Artikel
(589)
Buchkapitel
(16)
Bücher
(2)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(301)
Science & Technology
(298)
Life Sciences & Biomedicine
(293)
Hematology
(201)
Biological And Medical Sciences
(168)
Medical Sciences
(157)
Female
(154)
Male
(150)
Adult
(140)
Middle Aged
(130)
Adolescent
(98)
Aged
(86)
Oncology
(84)
Child
(81)
Animals
(76)
Bone Marrow Transplantation
(76)
Transplantation, Homologous
(75)
Hematologic And Hematopoietic Diseases
(71)
Treatment Outcome
(66)
Hematopoietic Stem Cell Transplantation
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

How I treat refractory acute GVHD

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53 -Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Silver Lining: Reduced Relapse with Chronic GVHD after Transplant for MDS

Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?

A disease risk index for patients undergoing allogeneic stem cell transplantation

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

Asymmetric dimethylarginine - a prognostic marker for transplant outcome?

Who is fit for allogeneic transplantation?

Elevated TWIST1 expression in myelodysplastic syndromes/acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine

Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Aktive Filter

Suchergebnisse filtern